Skip to main content
. 2021 Apr;10(4):1732–1743. doi: 10.21037/tcr-20-3171

Figure 4.

Figure 4

LHRH-a/CPT-11/PLGA nanoparticles targeted inhibit tumor growth. (A) Subcutaneous xenotransplantation tumor model of human ovarian tumor in nude mice. (B) LHRH-a/CPT-11/PLGA target xenograft tumor (×800). (C) Growth curve of transplanted tumor in nude mice of each treatment group. (D) Weight of transplanted tumor in each group after treatment. LHRH-a, luteinizing hormone releasing hormone analogue; CPT-11, irinotecan HCl trihydrate; PLGA, poly lactic-co-glycolic acid. **, P<0.01; ***, P<0.001.